Intramyocardial Hemorrhage in Patients with Acute Myocardial Infarction Without Reperfusion Therapy: A Prospective

Muzheng Li1, Zhijian Wu2, Ilyas Tudahun3

  • 1Department of Cardiology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518107, People's Republic of China.

Insights

Myocardial hemorrhage (IMH) occurs in ST-elevation myocardial infarction (STEMI) patients even without reperfusion therapy, with a higher incidence than in non-ST-elevation myocardial infarction (NSTEMI) patients. This finding is crucial for understanding acute myocardial infarction (AMI) complications.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Acute Myocardial Infarction

Background:

  • Myocardial hemorrhage (IMH) is often associated with reperfusion therapy in ST-elevation myocardial infarction (STEMI).
  • The occurrence of IMH in acute myocardial infarction (AMI) patients without reperfusion therapy remains unclear.
  • Understanding IMH in non-reperfusion settings is critical for comprehensive patient management.

Purpose of the Study:

  • To investigate the incidence and characteristics of IMH in patients with STEMI and NSTEMI who did not receive reperfusion therapy.
  • To compare the incidence of IMH between STEMI and NSTEMI patients in the absence of reperfusion.
  • To explore the relationship between IMH and major adverse cardiovascular events (MACE) in STEMI patients without reperfusion.

Main Methods:

  • Prospective enrollment of 40 STEMI and 41 NSTEMI patients who did not undergo reperfusion therapy.
  • Cardiac Magnetic Resonance (CMR) imaging to detect IMH.
  • Comparison of IMH incidence between STEMI and NSTEMI groups.
  • Analysis of MACE in STEMI patients with and without IMH.

Main Results:

  • IMH was detected in 16 out of 40 STEMI patients (40%) and 3 out of 41 NSTEMI patients (7.3%), P < 0.001.
  • The incidence of IMH in STEMI patients was comparable regardless of whether they underwent primary percutaneous coronary intervention (16/40) or not (27/65), P = 0.876.
  • STEMI patients with IMH showed a trend towards higher MACE (5/16) compared to those without IMH (2/24), P = 0.063.

Conclusions:

  • Myocardial hemorrhage (IMH) occurs in STEMI patients even without reperfusion therapy.
  • The incidence of IMH is significantly higher in STEMI compared to NSTEMI patients, irrespective of reperfusion status.
  • IMH in STEMI patients, even without restored infarct-related vessel flow, may be associated with adverse outcomes.
Abstract